Fresenius Medical Care AG & Co. KGaA  / Key word(s): Final Results

26.02.2013 07:01

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Fresenius Medical Care has achieved its targets for the financial year
2012.

Net revenue of Fresenius Medical Care AG & Co. KGaA for the full year 2012
was $13,800 million, up by 10% from the full year 2011.

Operating income (EBIT) for the full year 2012 increased by 7% to $2,219
million compared to $2,075 million for the full year 2011. Excluding
one-time costs the operating income for the full year 2012 increased by 12%
to $2,329 million.

For the full year 2012, net income attributable to shareholders of
Fresenius Medical Care AG & Co. KGaA was $1,187 million, up 11% from the
full year 2011. Excluding a positive non-taxable investment gain in the
amount of $140 million and one-time costs in the amount of $71 million, net
income attributable to shareholders of Fresenius Medical Care AG & Co. KGaA
was $1,118 million, an increase of 4% compared to 2011.

For the 16th consecutive year shareholders can expect to receive an
increased annual dividend. At the Annual General Meeting to be held on May
16, 2013, shareholders will be asked to approve a dividend per ordinary
share of EUR0.75, an increase of 9% (2011: EUR0.69).

For the full year 2013, Fresenius Medical Care expects revenue to grow to
more than $14.6 billion. Net income attributable to shareholders of
Fresenius Medical Care AG & Co. KGaA is expected to be between $1.1 and
$1.2 billion. Based on the net income for 2012 excluding the investment
gain, the expected earnings growth in 2013 is between 5% and 15%.

Fresenius SE & Co. KGaA (WKN 578560) holds 30.77% of Fresenius Medical Care
AG & Co. KGaA's capital.

Fresenius Medical Care AG & Co. KGaA
Represented by Fresenius Medical Care Management AG 
Represented by its Management Board 
Bad Homburg v.d.H., February 26, 2013


26.02.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Fresenius Medical Care AG & Co. KGaA
              Else-Kröner-Straße 1
              61352 Bad Homburg
              Germany
Phone:        +49 (0) 6172- 609 2525
Fax:          +49 (0) 6172- 609 2301
E-mail:       ir@fmc-ag.com
Internet:     www.fmc-ag.de
ISIN:         DE0005785802, DE0005785836, 
WKN:          578580, 578583
Indices:      DAX
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart;
              Terminbörse EUREX; NYSE
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------